Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for ...

A federal appeals court will hear arguments Friday in the Trump administration's effort to subpoena patient records on gender ...

In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...

Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots ...

The named families, as administrators of private rural Amish schools, are challenging $118,000 in state fines for not ...

WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave ...

Servier said it would buy Day One Biopharmaceuticals, the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion.

The DOJ's fight against gender-affirming care, the impact of Trump's 'Don't take Tylenol,' and more health news ...

Meanwhile, Moderna is trying to reset its future around oncology.

Kennedy Jr. are attempting to find common ground on one issue: the urgent need to take mental health and addiction seriously as national priorities. Despite the fact that mental health parity has been ...

Immediately after U.S. health officials linked Tylenol to autism, the drug's use in pregnant women visiting ERs dropped, new ...